On the other hand, while the NKp30 ligand soluble BAG6, released by lymphocytic leukemia cells, works as an inhibitory ligand of NKp30, exosome-bound BAG6 activates NK cells in chronic lymphocytic leukemia (CLL) [79]. The gene discussed is NCR3; the disease is lymphoid leukemia.